About: Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 November 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2012 (uk) im November 2012 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 13 November 2012 (en) artículu científicu espublizáu en payares de 2012 (ast)
publication date	wds:Q85445453-A8C13F48-EB27-4182-B7F0-408FD65A7772
publication date	2012-11-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q85445453-D2BB26DC-D42F-470A-AB81-C2A051AAA00A
language of work or name	English
cites work	wds:Q85445453-10D28E10-D647-4093-B6B7-2017D8D2C85A wds:Q85445453-15E3441E-C995-466D-8AF4-E21E95D295A0 wds:Q85445453-1774F74B-BC0E-4315-A16B-3D93EDD3EFEA wds:Q85445453-1BD318D9-F23C-44C0-93DF-80EB8EF040C7 wds:Q85445453-2ED18B77-02F8-4216-8203-21DA54CED44A wds:Q85445453-3A6C6FFF-1195-4334-8018-8B17DD542413 wds:Q85445453-3E90BDE9-D1DC-410C-A121-1D368E09B532 wds:Q85445453-43D05CCB-A7B8-4345-AD05-C2AA474B601C wds:Q85445453-472CD02C-3005-488F-8000-65D7C7139F69 wds:Q85445453-477B7F17-C567-4223-AB3A-9DF0A8C99E8A wds:Q85445453-52D85416-314F-4FA3-9AFE-9701B1C9000C wds:Q85445453-685D9979-2823-4731-BEDA-CC6A54C9B0A3 wds:Q85445453-8F722D5C-58BF-4885-9CE9-AFAF85272DCE wds:Q85445453-8F842652-62EE-4514-9C8F-258C58146043 wds:Q85445453-A73F6585-C2E9-484E-B27E-A031DF5EB3D3 wds:Q85445453-BD28D1FE-FE46-458E-914A-9DAAF3889821 wds:Q85445453-D3B4AA32-9C68-4409-9F53-DE5DD42C0367 wds:Q85445453-E69D3750-EF8D-40D0-BB29-2A784E57C62D wds:Q85445453-F3875E61-637C-44AA-AEC2-E540CA0B40C9 wds:Q85445453-F6C438AB-B2DF-4E89-86A6-CD10952F8045 wds:Q85445453-FBF28D4B-9D2F-4B7D-A4D5-5DC005F0A4A7
cites work	EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination Chromogranin-A expression in gastric and colon cancer tissues Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy International variation in prostate cancer incidence and mortality rates. Neuroendocrine differentiation in the progression of prostate cancer Hepatic resection: the last surgical frontier for colorectal cancer New circulating biomarkers for prostate cancer Potential clinical value of circulating chromogranin A in patients with prostate carcinoma The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy Plasma chromogranin A: clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy [Role of neuroendocrine cells in prostate cancer progression] Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay Distribution of high chromogranin A serum levels in patients with nonmetastatic and metastatic prostate adenocarcinoma. Implications of circulating chromogranin A in prostate cancer Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy Assessment of serum chromogranin-A as prognostic factor in high-risk prostate cancer Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsy. Molecular markers for prostatic cancer Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma Predicting non-organ-confined prostate cancer in men diagnosed after 2000.
author name string	wds:Q85445453-55524BE3-010D-4068-AA42-D7C02B2F08E4 wds:Q85445453-6B25BC45-505A-4274-ACB0-6D703DC4E0CF wds:Q85445453-760299DF-0092-447E-AF25-E528E123F1E6 wds:Q85445453-7C0F2D85-755B-4A0F-AEDC-C8C3BB4E09A6
author name string	Andrea Tubaro Riccardo Lombardo Simone Albisinni Fabiana Cancrini
rdfs:label	Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (en) Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (nl)
skos:prefLabel	Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (en) Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (nl)
name	Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (en) Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (nl)
author	wds:Q85445453-3D13D942-2BD5-4335-A63A-90A0EFBE3645 wds:Q85445453-F9A9C8AB-785B-4999-B889-8505FBCC112E
author	Cosimo De Nunzio Fabrizio Presicce
title	wds:Q85445453-FA1DBDA4-B577-401E-A869-99E574D86909
title	Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort (en)
page(s)	wds:Q85445453-33205BB8-C2D2-4584-A1B3-BA81B7207BCC
page(s)	80-84
instance of	wds:Q85445453-6555A5AD-FDE4-4BAE-B969-B2AEC08D2094
instance of	scholarly article
main subject	wds:Q85445453-616D1B51-F5CF-4116-B923-61A27598AB31
main subject	prostate cancer
PubMed ID	wds:Q85445453-A0431A0E-1A68-4F25-B520-80C33A78B638
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23153859
PubMed ID	23153859
published in	wds:Q85445453-A4C8C267-CEC1-4DF3-ABD5-161027FC8DD9
published in	Urologic Oncology
issue	wds:Q85445453-EC713E74-D42B-4CFB-BC47-89D2F5D3B4E1
volume	wds:Q85445453-D1BFC125-D521-4838-A8C9-AF469BD27AC5
issue	2
volume	32
DOI	wds:Q85445453-80DD4E63-E6AE-463B-AD58-92302EDFF782
DOI	http://dx.doi.org/10.1016/J.UROLONC.2012.07.012
DOI	10.1016/J.UROLONC.2012.07.012
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q85445453
is cites work of	Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival. Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort. Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.
is cites work of	wds:Q64070884-86C17581-8D45-4F0D-9A47-8BD754B017AB wds:Q39067232-936B2465-8A81-4930-B778-1E5E30A0A56B wds:Q40099310-FC069363-C798-49ED-B6D2-3F0E6280CF05 wds:Q47193615-B32EA06B-8E43-4062-8210-62422F29EE3B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software